Picks of the Week: Allergies, Transplants and Deadly Infections
Each week, the editors at The Post's Investigations blog comb through in-depth and investigative reports from news outlets across the country and select notable projects of the week.
This week's top picks:
Mislabeled Products Endangering Children with Food Allergies
American children with food allergies are suffering life-threatening -- and completely avoidable -- reactions because manufacturers mislabel their products and regulators fail to police store shelves, a Chicago Tribune investigation found.
WSJ: Public Hospital Acting Like For-Profit Company
The University of Pittsburgh Medical Center once dominated the lucrative business of liver transplants and, in an aggressive bid to reclaim its leadership, the hospital hired an innovative surgeon who promised to double the number of transplants at the hospital. In doing so, however, the doctor resorted to practices that some colleagues found questionable, The Wall Street Journal found.
MRSA Infections Caused 672 Undisclosed Deaths in Washington
Millions of computerized hospital records, death certificates and other documents found evidence of one of the nation's most widespread, and preventable, epidemics, The Seattle Times found.
In its investigation -- the first comprehensive accounting of MRSA cases in Washington hospitals -- the newspaper gained access to state files that revealed 672 previously undisclosed deaths attributable to the infection.
By Derek Kravitz |
November 21, 2008; 7:24 PM ET
Top Picks
Previous: And The Vote Goes To... |
Next: Plea for a Pardon: The Hunt For a Free Pass








If you have solid tips, news or documents on potential ethical violations or abuses of power, we want to know. Send us your suggestions.

Unfortunately I believe that we are limited in what we can focus on. I think that if we proceed with the partisan sideshow of prosecuting Bush admin. officials, healthcare will get lost in the brouhaha.
The Washington Post's permanent investigative unit was set up in 1982 under Bob Woodward.
We encourage users to analyze, comment on and even challenge washingtonpost.com's articles, blogs, reviews and multimedia features.
User reviews and comments that include profanity or personal attacks or other inappropriate comments or material will be removed from the site. Additionally, entries that are unsigned or contain "signatures" by someone other than the actual author will be removed. Finally, we will take steps to block users who violate any of our posting standards, terms of use or privacy policies or any other policies governing this site. Please review the full rules governing commentaries and discussions.